Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass

NCT: NCT02471638 · COMPLETED

NCT IDNCT02471638
StatusCOMPLETED
Start Date2015-01
Completion2020-06
SponsorEndologix (INDUSTRY)
First posted
Last updated

Brief Summary

To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.

Frequently Asked Questions

What is DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass?

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass is a clinical trial registered under NCT02471638. Current status: COMPLETED.

What is the status of NCT02471638?

The current status of NCT02471638 (DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass) is: COMPLETED.

When did DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass start?

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass started on 2015-01.

Related Devices

PMA P220021Stent graft, bypass, superficial femoral arteryEndologix, LLC PMA P040002SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC PMA P120006SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENTEndologix, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑